Australia’s Star Entertainment reported a deeper-than-expected first-half loss as regulatory remediation costs and softer consumer spending continued to weigh heavily on the embattled casino operator. For the six months ending December 31, Star posted an underlying loss of A$136 million (US$86.2 million), missing the Visible Alpha consensus forecast of A$93.9 million. This marks a significant decline from the A$25 million profit posted in the same period a year earlier.
The company delayed its financial results by six weeks beyond its end-of-February deadline, citing uncertainty over its ability to continue operating amid declining revenue. Star noted that third-quarter revenue was down, impacted by fewer gaming visits and adverse weather conditions. Its flagship Sydney casino saw revenue drop 8% quarter-over-quarter, while operations at its Gold Coast property were disrupted by Cyclone Alfred, which forced a five-day closure and resulted in an estimated A$3 million EBITDA loss.
Ongoing regulatory scrutiny continues to challenge the company. Since 2021, Star has faced multiple investigations into alleged breaches of anti-money laundering and counter-terrorism laws, involving agencies such as AUSTRAC, the New South Wales Independent Casino Commission, and Queensland authorities.
Last week, Star secured a critical A$300 million rescue package from U.S.-based Bally’s Corporation after a planned loan from Salter Brothers Capital fell through. The company stated that final documentation for the Bally’s investment is expected within a week, with a shareholder vote scheduled for late June.
Trading in Star Entertainment shares remains halted following the announcement. As the company navigates its financial and legal hurdles, its future hinges on successful regulatory compliance and the approval of its refinancing deal.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



